Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathalie Jacque

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Presse Medicale (Paris, France : 1983)|August 27, 2019
[Chronic lymphocytic leukemia]Nathalie Jacque, Véronique Leblond
Oncoscience|January 17, 2015
Targeting glutamine uptake in AMLNathalie Jacque, Didier Bouscary
British Journal of Haematology|October 15, 2011
The eukaryotic initiating factor 4E protein is overexpressed, but its level has no prognostic impact in acute myeloid leukaemiaAlexa S Green, Sophie Grabar, Micheline Tulliez, et al.
Haematologica|July 14, 2022
Inflammation in Waldenström macroglobulinemia is associated with 6q deletion and need for treatment initiationNathalie Forgeard, Marine Baron, Jonathan Caron, et al.
Blood|September 10, 2013
Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemiaLise Willems, Nathalie Jacque, Arnaud Jacquel, et al.
Blood|July 19, 2015
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibitionNathalie Jacque, Anne Marie Ronchetti, Clément Larrue, et al.
Cell Reports|May 26, 2015
Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid LeukemiaPierre Sujobert, Laury Poulain, Etienne Paubelle, et al.
Blood|December 6, 2021
CAR T-cell therapy in primary central nervous system lymphoma: the clinical experience of the French LOC networkMarion Alcantara, Caroline Houillier, Marie Blonski, et al.
Science Advances|November 25, 2015
Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemiaAlexa S Green, Thiago T Maciel, Marie-Anne Hospital, et al.
American Journal of Hematology|April 8, 2024
CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC networkSylvain Choquet, Carole Soussain, Nabih Azar, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Presse Medicale (Paris, France : 1983)|August 27, 2019
[Chronic lymphocytic leukemia]Nathalie Jacque, Véronique Leblond
Oncoscience|January 17, 2015
Targeting glutamine uptake in AMLNathalie Jacque, Didier Bouscary
British Journal of Haematology|October 15, 2011
The eukaryotic initiating factor 4E protein is overexpressed, but its level has no prognostic impact in acute myeloid leukaemiaAlexa S Green, Sophie Grabar, Micheline Tulliez, et al.
Haematologica|July 14, 2022
Inflammation in Waldenström macroglobulinemia is associated with 6q deletion and need for treatment initiationNathalie Forgeard, Marine Baron, Jonathan Caron, et al.
Blood|September 10, 2013
Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemiaLise Willems, Nathalie Jacque, Arnaud Jacquel, et al.
Blood|July 19, 2015
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibitionNathalie Jacque, Anne Marie Ronchetti, Clément Larrue, et al.
Cell Reports|May 26, 2015
Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid LeukemiaPierre Sujobert, Laury Poulain, Etienne Paubelle, et al.
Blood|December 6, 2021
CAR T-cell therapy in primary central nervous system lymphoma: the clinical experience of the French LOC networkMarion Alcantara, Caroline Houillier, Marie Blonski, et al.
Science Advances|November 25, 2015
Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemiaAlexa S Green, Thiago T Maciel, Marie-Anne Hospital, et al.
American Journal of Hematology|April 8, 2024
CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC networkSylvain Choquet, Carole Soussain, Nabih Azar, et al.
Pageof 2